Sign in
Explore the registryTrack Camizestrant's trials

CAMBRIA-2

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

CamizestrantOngoingActive not recruitingPhase 3Open NCT05952557 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

CAMBRIA-2 · Trial Tracker · ComplyRx